A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

Denise Haslwanter, Rohit K. Jangra(Louisiana State University Health Sciences Center Shreveport), Kathryn E. Dye(Mount St. Mary's University), Amanda Mengotto(New York University), John M. Dye(United States Army Medical Research Institute of Infectious Diseases), Johanna P. Daily(Albert Einstein College of Medicine), Olivia Vergnolle(Albert Einstein College of Medicine), Ethan Laudermilch, Gorka Lasso(Albert Einstein College of Medicine), Cecilia M. O’Brien(United States Army Medical Research Institute of Infectious Diseases), Jonathan R. Lai(Albert Einstein College of Medicine), Robert H. Bortz, Anna Z. Wec(Adimab (United States)), Ariel S. Wirchnianski(Albert Einstein College of Medicine), Daniel Wrapp(Duke University), C. Garrett Rappazzo(Adimab (United States)), M. Eugenia Dieterle, Mrunal Sakharkar(Adimab (United States)), Andrew S. Herbert(United States Army Medical Research Institute of Infectious Diseases), Laura M. Walker(Children's Hospital of Philadelphia), George I. Georgiev(Albert Einstein College of Medicine), Catalina Florez(United States Military Academy), J. Maximilian Fels(Albert Einstein College of Medicine), Ryan J. Malonis(Albert Einstein College of Medicine), Nianshuang Wang(The University of Texas at Austin), Jason Barnhill(United States Military Academy), Jose A. Quiroz(Albert Einstein College of Medicine), Karen Tong(Albert Einstein College of Medicine), Kartik Chandran(Albert Einstein College of Medicine), Jason S. McLellan(The University of Texas at Austin)
mBio
October 5, 2021
Cited by 61


Related Papers